Literature DB >> 441676

Carcinoembryonic antigen (CEA) in patients with alcoholic liver diseases.

H Bell, H Orjasaeter, H F Lange.   

Abstract

The mean plasma carcinoembryonic antigen (CEA) level was found to be significantly increased in 66 patients with alcoholic liver disease (4.4 micrograms/1) compared with the mean CEA level in 164 healthy blood donors (1.6 micrograms/1, p less than 0.001). Eighteen of the patients (27%) had values above our upper normal values of 5 micrograms/1, compared with 3 of 41 (7%) in a group of patients with non-alcoholic liver diseases. On the other hand, the mean CEA values in the two groups did not differ significantly. The CEA level remained unchanged in patients who continued drinking. However, in 20 patients who stopped drinking, the mean CEA levels dropped significantly from 6.6 micrograms/1 to 3.7 micrograms/1. Concomitant fluctuations were seen in CEA, gamma-glutamyltranspeptidase (gamma-GT), asparate aminotransferase (ASAT), and alkaline phosphatase, although a significant correlation was found only between CEA level and the level of gamma-GT (r = 0.32, p less than 0.02). The correlation between CEA and gamma-GT was best in 41 patients without complicating disorders (r = 0.55, p less than 0.001). CEA was significantly increased in patients with complicating disorders. Much of the increase of CEA in many patients with alcoholic liver disease might be secondary to complicating disorders in the respiratory and/or gastrointestinal tracts. This could possible explain why patients with alcoholic liver disease more often than other patients with benign diseases have elevated CEA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 441676     DOI: 10.3109/00365527909179883

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Enhanced colorectal cancer metastases in the alcohol-injured liver.

Authors:  Ashley M Mohr; John J Gould; Jacy L Kubik; Geoffrey A Talmon; Carol A Casey; Peter Thomas; Dean J Tuma; Benita L McVicker
Journal:  Clin Exp Metastasis       Date:  2017-02-06       Impact factor: 5.150

2.  Hydroxylated collagen peptide in urine as biomarker for detecting colorectal liver metastases.

Authors:  Zarina S Lalmahomed; Mirelle Ee Bröker; Nick A van Huizen; Robert R J Coebergh van den Braak; Lennard Jm Dekker; Dimitris Rizopoulos; Cornelis Verhoef; Ewout W Steyerberg; Theo M Luider; Jan Nm IJzermans
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

Review 3.  The detection and evaluation of human tumor metastases.

Authors:  D J Laurence; A M Neville
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.